Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gorman

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Journal of Experimental Medicine|November 25, 2015
Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activationBinh L Phong, Lyndsay Avery, Tina L Sumpter, et al.
Scientific Reports|September 15, 2016
Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathwaysLing-Ling An, Jacob V Gorman, Geoffrey Stephens, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1992
Abundant expression of parathyroid hormone-related protein in human amnion and its association with laborJ E Ferguson, J V Gorman, D E Bruns, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2014
Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infectionJacob V Gorman, Gabriel Starbeck-Miller, Nhat-Long L Pham, et al.
Journal for Immunotherapy of Cancer|April 3, 2025
Impact of tumor localization on antitumor immunity with conditionally activated CTLA-4 blockadeMarcel Arias-Badia, Chien-Chun Steven Pai, Yee May Lwin, et al.
Nature Immunology|July 31, 2012
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Shigeki Chiba, Muhammad Baghdadi, Hisaya Akiba, et al.
European Journal of Immunology|December 7, 2011
Tim-1 regulates Th2 responses in an airway hypersensitivity modelMiranda L Curtiss, Jacob V Gorman, Thomas R Businga, et al.
JCI Insight|February 27, 2025
Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4Marcel Arias-Badia, PeiXi Chen, Yee May Lwin, et al.
Journal of Medicinal Chemistry|October 1, 2024
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with <i>In Vivo</i> Target EngagementRobin R Frey, Navendu Jana, Jacob V Gorman, et al.
Journal of Medicinal Chemistry|September 16, 2024
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase InhibitorYiyun Yu, Miyeon Jang, Julie Miyashiro, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Experimental Medicine|November 25, 2015
Tim-3 enhances FcεRI-proximal signaling to modulate mast cell activationBinh L Phong, Lyndsay Avery, Tina L Sumpter, et al.
Scientific Reports|September 15, 2016
Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathwaysLing-Ling An, Jacob V Gorman, Geoffrey Stephens, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1992
Abundant expression of parathyroid hormone-related protein in human amnion and its association with laborJ E Ferguson, J V Gorman, D E Bruns, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2014
Tim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infectionJacob V Gorman, Gabriel Starbeck-Miller, Nhat-Long L Pham, et al.
Journal for Immunotherapy of Cancer|April 3, 2025
Impact of tumor localization on antitumor immunity with conditionally activated CTLA-4 blockadeMarcel Arias-Badia, Chien-Chun Steven Pai, Yee May Lwin, et al.
Nature Immunology|July 31, 2012
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Shigeki Chiba, Muhammad Baghdadi, Hisaya Akiba, et al.
European Journal of Immunology|December 7, 2011
Tim-1 regulates Th2 responses in an airway hypersensitivity modelMiranda L Curtiss, Jacob V Gorman, Thomas R Businga, et al.
JCI Insight|February 27, 2025
Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4Marcel Arias-Badia, PeiXi Chen, Yee May Lwin, et al.
Journal of Medicinal Chemistry|October 1, 2024
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with <i>In Vivo</i> Target EngagementRobin R Frey, Navendu Jana, Jacob V Gorman, et al.
Journal of Medicinal Chemistry|September 16, 2024
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase InhibitorYiyun Yu, Miyeon Jang, Julie Miyashiro, et al.
Pageof 2